How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma.
about
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How to assess the efficacy or ...... b in hepatocellular carcinoma.
@en
How to assess the efficacy or ...... b in hepatocellular carcinoma.
@nl
type
label
How to assess the efficacy or ...... b in hepatocellular carcinoma.
@en
How to assess the efficacy or ...... b in hepatocellular carcinoma.
@nl
prefLabel
How to assess the efficacy or ...... b in hepatocellular carcinoma.
@en
How to assess the efficacy or ...... b in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
How to assess the efficacy or ...... b in hepatocellular carcinoma.
@en
P2093
Jean-Luc Raoul
Julien Edeline
Marine Gilabert
Xavier Adhoute
P2860
P304
P356
10.4254/WJH.V8.I35.1541
P577
2016-12-01T00:00:00Z